Compare GSK plc (GSK) vs Vertiv Holdings Co (VRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Vertiv Holdings Co — how do they compare? GSK plc trades at $50.5 (market cap $102.60B), while Vertiv Holdings Co trades at $291.2 (market cap $108.49B). The key difference: GSK plc and Vertiv Holdings Co are close in size by market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| GSK | VRT | |
|---|---|---|
Market Cap | $102.60B | $108.49B |
Sector | Health | Technology |
52-Week High | $61.18 | $376.23 |
52-Week Low | $38.22 | $121.82 |
Enterprise Value | $123.04B | $108.72B |
Dividend Yield | 3.57% | 0.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Vertiv Holdings Co
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →
